Home > Boards > US Listed > Biotechs > United Therapeutics Corporation (UTHR)

UTHR @ 196.30 > United Therapeutics shares are

Public Reply | Private Reply | Keep | Last ReadPost New MsgPrevious | Next
crudeoil24 Member Profile
Member Level 
Followed By 689
Posts 46,158
Boards Moderated 6
Alias Born 12/12/04
160x600 placeholder
United Therapeutics Pursues New Claims For Trade Secret Misappropriation Against Liquidia PR Newswire (US) - 6/7/2021 6:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/3/2021 6:03:55 AM
United Therapeutics Announces First Patient Enrolled In Phase 3 TETON Study Of Tyvaso In Patients With Idiopathic Pulmonary F... PR Newswire (US) - 6/3/2021 6:00:00 AM
Specialized Disclosure Report (sd) Edgar (US Regulatory) - 6/1/2021 4:31:09 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/28/2021 4:42:57 PM
United Therapeutics Corporation To Present At The Jefferies Virtual Healthcare Conference PR Newswire (US) - 5/25/2021 6:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/12/2021 4:35:26 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/10/2021 4:33:42 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/10/2021 4:32:24 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/6/2021 4:41:05 PM
United Therapeutics EPS in-line, beats on revenue Seeking Alpha - 5/5/2021 6:01:28 AM
United Therapeutics Corporation Reports First Quarter 2021 Financial Results PR Newswire (US) - 5/5/2021 6:00:00 AM
United Therapeutics Q1 2021 Earnings Preview Seeking Alpha - 5/4/2021 1:00:01 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/29/2021 4:31:17 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/29/2021 6:47:34 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/29/2021 6:23:28 AM
United Therapeutics Corporation To Report First Quarter 2021 Financial Results Before The Market Opens On Wednesday, May 5, 2... PR Newswire (US) - 4/26/2021 6:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/22/2021 4:32:26 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/19/2021 6:04:37 AM
United Therapeutics Announces Submission of Tyvaso DPI™ New Drug Application to FDA PR Newswire (US) - 4/19/2021 6:00:00 AM
Mannkind and United Therapeutics Reach a Milestone in the Development of Tyvaso DPI™ With New Drug Application Submitted to... GlobeNewswire Inc. - 4/19/2021 6:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/16/2021 4:34:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/15/2021 4:34:11 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/2/2021 9:35:55 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/2/2021 9:34:27 AM
crudeoil24 Member Level  Thursday, 04/01/21 11:36:08 AM
Re: $Pistol Pete$ post# 15
Post # of 26 
UTHR @ 196.30 > United Therapeutics shares are trading higher after the company announced that the FDA approved the launch of its Tyvaso for the treatment of pulmonary hypertension associated with interstitial lung disease.

New York Yankees and Duke Basketball
Public Reply | Private Reply | Keep | Last ReadPost New MsgPrevious | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences